Samantha E Shockley

Title: Innovations of Samantha E Shockley

Introduction

Samantha E Shockley is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various health conditions. With a total of 2 patents to her name, her work is recognized for its potential impact on treating serious diseases.

Latest Patents

Samantha's latest patents focus on Diacylglyceride O-acyltransferase 2 (DGAT2) inhibitors. These inventions include compounds of formula I and their pharmaceutically acceptable salts, esters, and prodrugs. The patents also detail methods for synthesizing these compounds, as well as pharmaceutical compositions that incorporate them. The applications of these compounds are extensive, targeting conditions such as hepatic steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, type-2 diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, cognitive decline, dementia, and cardiorenal diseases like chronic kidney disease and heart failure.

Career Highlights

Samantha is currently employed at Merck Sharp & Dohme Corporation, where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to addressing complex health issues through scientific research and development.

Collaborations

Throughout her career, Samantha has collaborated with notable colleagues, including Cedric Lorenz Hugelshofer and Victor W Mak. These partnerships have contributed to the advancement of her research and the successful development of her patented inventions.

Conclusion

Samantha E Shockley exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through her patents and collaborations highlight her dedication to improving health outcomes for patients worldwide.